At the ALS Center Karolinska, we integrate clinical care with clinical- and preclinical research. Our main research focus is epidemiological research, risk and prognosis, quality of life, wet and dry biomarkers. All patients are part of the national Swedish MND registry, which is based in our clinic. To give patients and their families an opportunity to participate in clinical trials, the ALS Treatment Center Karolinska (ALS Treat) was established in cooperation with the clinic and conducts several clinical trials of ALS.
Amylyx Pharmaceuticals Inc is conducting a phase 3 trial to determine the safety and efficacy of their compound ‘AMX0035’ for the treatment of ALS.